OSAKA, Japan & CAMBRIDGE, Mass.--(Enterprise WIRE)--Takeda Pharmaceutical Organization Constrained (TSE:4502/NYSE:TAK) (“Takeda”) currently outlined its ambition for earlier mentioned-current market, double-digit...
years1
OSAKA, Japan & CAMBRIDGE, Mass.--(Small business WIRE)--Mar 11, 2021--Takeda Pharmaceutical Company Minimal( TSE:4502/NYSE:TAK ) (“Takeda”) nowadays outlined its ambition for...
Aiming for Revenues of JPY 1 Trillion (roughly US$9 Billion2) by FY2030Double-Digit Income Development Envisioned to be Driven by a...